Parralax (4.5billion dollar medical/biotech hedge fund) now owns 27%, as of 6/31 due to recent filing -- potentially through confidential filing acquisition? Some other entity may have taken a large >5% position on 8/5, due to that volume spike.
PUR1800 P1B Data publication soon - which will open doors to IPF/Chronic indications, and re-entrance of JnJ partnerships?
Lots of other *ongoing* catalysts that could hit, such as Oexia, Nocion, other licenses/partnerships.
Think the company is ready and funds are supporting the effort for a big pop, just my opinion.
News 
Market Data 
Discover 
